DK1740574T3 - 4-amino-5-cyanopyrimidinderivater - Google Patents

4-amino-5-cyanopyrimidinderivater

Info

Publication number
DK1740574T3
DK1740574T3 DK05738867T DK05738867T DK1740574T3 DK 1740574 T3 DK1740574 T3 DK 1740574T3 DK 05738867 T DK05738867 T DK 05738867T DK 05738867 T DK05738867 T DK 05738867T DK 1740574 T3 DK1740574 T3 DK 1740574T3
Authority
DK
Denmark
Prior art keywords
amino
cyanopyrimidine derivatives
cyanopyrimidine
derivatives
Prior art date
Application number
DK05738867T
Other languages
Danish (da)
English (en)
Inventor
Masaya Kato
Norifumi Sato
Minoru Okada
Tetsuyuki Uno
Nobuaki Ito
Yasuhiro Takeji
Hisashi Shinohara
Masahiro Fuwa
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1740574T3 publication Critical patent/DK1740574T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK05738867T 2004-04-30 2005-04-28 4-amino-5-cyanopyrimidinderivater DK1740574T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004135999 2004-04-30
PCT/JP2005/008568 WO2005105778A2 (fr) 2004-04-30 2005-04-28 Dérivés de 4-amino-5-cyanopyrimidine

Publications (1)

Publication Number Publication Date
DK1740574T3 true DK1740574T3 (da) 2007-10-15

Family

ID=35242255

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05738867T DK1740574T3 (da) 2004-04-30 2005-04-28 4-amino-5-cyanopyrimidinderivater

Country Status (22)

Country Link
US (2) US7834002B2 (fr)
EP (1) EP1740574B1 (fr)
KR (1) KR101279689B1 (fr)
CN (1) CN1976922B (fr)
AR (1) AR049085A1 (fr)
AT (1) ATE365731T1 (fr)
AU (1) AU2005238391B2 (fr)
BR (1) BRPI0509454A (fr)
CA (1) CA2563846C (fr)
CY (1) CY1106764T1 (fr)
DE (1) DE602005001508T2 (fr)
DK (1) DK1740574T3 (fr)
ES (1) ES2288744T3 (fr)
HK (1) HK1100775A1 (fr)
MX (1) MXPA06012639A (fr)
MY (1) MY138996A (fr)
PL (1) PL1740574T3 (fr)
PT (1) PT1740574E (fr)
RU (1) RU2386628C2 (fr)
SI (1) SI1740574T1 (fr)
TW (1) TWI346109B (fr)
WO (1) WO2005105778A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2665490C (fr) * 2006-10-03 2014-06-17 The Trustees Of The University Of Pennsylvania Procede pour traiter une degenerescence maculaire
TWI452044B (zh) 2007-06-15 2014-09-11 Mitsubishi Tanabe Pharma Corp 嗎啉衍生物
WO2009115557A2 (fr) * 2008-03-19 2009-09-24 Bayer Cropscience Sa Dérivés de l'hydroximoyl-tétrazole fongicides
AR075196A1 (es) * 2009-02-03 2011-03-16 Otsuka Pharma Co Ltd Un derivado de cianopirimidina para el tratamiento de una enfermedad ocular
DK2807178T3 (en) * 2012-01-26 2017-09-04 Inotek Pharmaceuticals Corp Anhydrous polymorphs of (2R, 3S, 4R, 5R) -5- (6- (cyclopentylamino) -9H-purin-9-yl) -3,4-dihydroxytetrahydrofuran-2-yl) methyl nitrate and processes for their preparation
EP2816023A4 (fr) * 2012-02-13 2015-09-09 Takeda Pharmaceutical Composé à noyaux aromatiques
WO2019051396A1 (fr) * 2017-09-08 2019-03-14 President And Fellows Of Harvard College Inhibiteurs à petites molécules des virus ébola et de la fièvre de lassa, et leurs procédés d'utilisation
WO2019072143A1 (fr) * 2017-10-11 2019-04-18 上海迪诺医药科技有限公司 Dérivé de 4-aminopyridine, composition pharmaceutique contenant celui-ci, procédé de préparation associé et utilisation correspondante

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6299395A (ja) 1985-10-25 1987-05-08 Yamasa Shoyu Co Ltd 2−アルキニルアデノシンおよび抗高血圧剤
US4968697A (en) 1987-02-04 1990-11-06 Ciba-Geigy Corporation 2-substituted adenosine 5'-carboxamides as antihypertensive agents
DE68916036T2 (de) 1988-11-15 1994-09-29 Toa Eiyo Ltd Mittel zur behandlung und prophylaxe koronarer und zerebraler ischämischer erkrankungen.
IT1254915B (it) 1992-04-24 1995-10-11 Gloria Cristalli Derivati di adenosina ad attivita' a2 agonista
US5877180A (en) 1994-07-11 1999-03-02 University Of Virginia Patent Foundation Method for treating inflammatory diseases with A2a adenosine receptor agonists
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
SE9703378D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
AR017457A1 (es) 1998-02-14 2001-09-05 Glaxo Group Ltd Compuestos derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol, procesos para su preparacion, composiciones que los contienen y su uso en terapia para el tratamiento de enfermedades inflamatorias.
GB9813535D0 (en) 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB9813565D0 (en) 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
GB9813540D0 (en) 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
CA2335809A1 (fr) 1998-06-23 1999-12-29 Glaxo Group Limited Derives du 2-(purin-9-yl)-tetrahydrofuran-3,4 diol
JP2002173427A (ja) 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物
DE69932173T2 (de) 1998-10-16 2007-06-06 Pfizer Inc. Adeninderivate
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
GB9913932D0 (en) 1999-06-15 1999-08-18 Pfizer Ltd Purine derivatives
JP2003502434A (ja) 1999-06-22 2003-01-21 スィーヴィー セラピューティクス インコーポレイテッド チオフェンa2a受容体アゴニスト
US6403567B1 (en) 1999-06-22 2002-06-11 Cv Therapeutics, Inc. N-pyrazole A2A adenosine receptor agonists
US6180615B1 (en) 1999-06-22 2001-01-30 Cv Therapeutics, Inc. Propargyl phenyl ether A2A receptor agonists
US6214807B1 (en) 1999-06-22 2001-04-10 Cv Therapeutics, Inc. C-pyrazole 2A A receptor agonists
DE19947154A1 (de) 1999-10-01 2001-10-04 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
GB9924361D0 (en) 1999-10-14 1999-12-15 Pfizer Ltd Purine derivatives
DE10110438A1 (de) 2001-03-05 2002-09-19 Bayer Ag Substituierte 2-Oxy-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10110747A1 (de) 2001-03-07 2002-09-12 Bayer Ag Substituierte 2,6-Diamino-3,5-dicyano-4-aryl-pyridine und ihre Verwendung
DE10110754A1 (de) 2001-03-07 2002-09-19 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10115945A1 (de) 2001-03-30 2002-10-02 Bayer Ag Substituierte 2-Carba-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10115922A1 (de) 2001-03-30 2002-10-10 Bayer Ag Cyclisch substituierte 2-Thio-3,5-dicyano-4-aryl-6-aminopyridine und ihre Verwendung
DE10134481A1 (de) 2001-07-16 2003-01-30 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
JP2003055395A (ja) 2001-08-10 2003-02-26 Toa Eiyo Ltd アデノシン誘導体
DE10238113A1 (de) 2001-12-11 2003-06-18 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
JP2003206230A (ja) 2002-01-10 2003-07-22 Yamanouchi Pharmaceut Co Ltd シアノヘテロ環誘導体又はその塩

Also Published As

Publication number Publication date
AU2005238391B2 (en) 2010-12-16
KR20070008715A (ko) 2007-01-17
US20110009620A1 (en) 2011-01-13
US7989446B2 (en) 2011-08-02
CA2563846C (fr) 2011-12-20
SI1740574T1 (sl) 2007-12-31
EP1740574B1 (fr) 2007-06-27
CN1976922A (zh) 2007-06-06
PT1740574E (pt) 2007-09-06
DE602005001508D1 (de) 2007-08-09
WO2005105778A2 (fr) 2005-11-10
CN1976922B (zh) 2012-09-05
US20080182854A1 (en) 2008-07-31
WO2005105778A3 (fr) 2006-10-26
RU2386628C2 (ru) 2010-04-20
AU2005238391A1 (en) 2005-11-10
BRPI0509454A (pt) 2007-09-04
TWI346109B (en) 2011-08-01
HK1100775A1 (en) 2007-09-28
US7834002B2 (en) 2010-11-16
AR049085A1 (es) 2006-06-28
DE602005001508T2 (de) 2008-02-28
KR101279689B1 (ko) 2013-06-27
ES2288744T3 (es) 2008-01-16
ATE365731T1 (de) 2007-07-15
CY1106764T1 (el) 2012-05-23
MY138996A (en) 2009-08-28
EP1740574A2 (fr) 2007-01-10
PL1740574T3 (pl) 2007-11-30
CA2563846A1 (fr) 2005-11-10
MXPA06012639A (es) 2006-12-15
TW200540161A (en) 2005-12-16
RU2006142323A (ru) 2008-06-10

Similar Documents

Publication Publication Date Title
IS8578A (is) 3- karbamoýl - 2- pýridón afleiður
DK1725553T3 (da) Tetrahydropyridoindolderivater
DK1761541T3 (da) Pyrrazolo-pyrimidin-derivater
ATE540935T1 (de) Chinazolinderivate
ATE417830T1 (de) Sulfonylbenzimidazolderivate
ATE553079T1 (de) Heteroarylphenylharnstoffderivat
ATE392425T1 (de) Thiazolyl-dihydro-indazole
DE602005024580D1 (de) Universalgleitnocken
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE430142T1 (de) Phenylpiperazin-methanon-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
DE602005004840D1 (de) Erntegutabstreifer
DK1971588T3 (da) Tiglien-3-onderivater
ATE404542T1 (de) 4-phenylpyrimidin-2-carbonitrilderivate
ATE365731T1 (de) 4-amino-5-cyanopyrimidinderivate
NO20056129L (no) Spunstonne
AT500198B8 (de) Ladewagen
ATE389633T1 (de) Omega-phenyloctanamide
ATE541837T1 (de) Oxaphenanthren-derivate
AT500249A3 (de) Scheibenegge
FR2872867B1 (fr) Aero-turbo-generateur
DE602006019209D1 (de) Fluoroalkylpyrrolidin-derivate
NO20044489D0 (no) Stotfangeersystem
ATA9982004A (de) Tiefbohrbrunnen